Delisting riskPopularity #4,595
MBAI · NASDAQ · Biotechnology

Check-Cap (MBAI)

Maintains legacy C-Scan assets while pursuing a merger with embodied-AI operator MBody.

$6.08
vs last close−0.30 (−4.73%)